Pancreatic Cancer Research

ResearcherInstituto de Investigación Marqués de ValdecillaActive in the last 2 years

Fernando Rivera Herrero

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8915-226X; OpenAlex author ID A5085058149. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 11

  1. Sonic hedgehog inhibitor suppresses carcinoma associated fibroblasts to prime Gemcitabine/Nab-Paclitaxel and anti-CTLA4 immunotherapy as sequential first-line … Co-author DOI 10.64898/2025.12.14.25342225↗
  2. Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer. Co-author DOI 10.1056/evidoa2300144↗
  3. Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine i… Co-author DOI 10.1016/j.annonc.2019.09.004↗
  4. Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel a… Co-author DOI 10.1016/j.annonc.2020.05.011↗
  5. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Co-author DOI 10.1016/s2468-1253(19)30327-9↗
  6. Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study. Co-author DOI 10.1016/j.pan.2018.10.004↗
  7. Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cance… Co-author DOI 10.1200/jco.18.00089↗
  8. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety … Co-author DOI 10.1016/j.ejca.2016.12.032↗
  9. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, rand… Co-author DOI 10.1016/s0140-6736(15)00986-1↗
  10. Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: resul… Co-author DOI 10.1586/14737167.2015.1047349↗
  11. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer. Co-author DOI 10.1007/s12094-014-1177-7↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Teresa Mercade Macarulla · 4 shared papers, 2015–2025 · strength 0.50
  2. Carmen Guillén‐Ponce · 4 shared papers, 2017–2024 · strength 0.41
  3. Roberto Pazo-Cid · 4 shared papers, 2017–2024 · strength 0.38
  4. Javier Gallego-Plazas · 4 shared papers, 2014–2024 · strength 0.37
  5. Manuel M. Hidalgo · 2 shared papers, 2019–2025 · strength 0.28
  6. Alfredo Carrato Mena · 3 shared papers, 2014–2024 · strength 0.26
  7. Enrique Aranda Aguilar · 3 shared papers, 2014–2024 · strength 0.26
  8. Carles Pericay Pijaume · 2 shared papers, 2014–2024 · strength 0.21
  9. Manuel Benavides · 3 shared papers, 2014–2019 · strength 0.20
  10. Valerie S. Kalluri · 1 shared paper, 2025 · strength 0.20
  11. Raghu Kalluri · 1 shared paper, 2025 · strength 0.20
  12. Bruno Bockorny · 1 shared paper, 2025 · strength 0.20
  13. Andrew H. Ko · 2 shared papers, 2020 · strength 0.18
  14. Syed Farhan Zafar · 2 shared papers, 2020 · strength 0.18
  15. David J. Watkins · 2 shared papers, 2020 · strength 0.18
  16. Uwe Pelzer · 2 shared papers, 2020 · strength 0.18
  17. Hana Algül · 2 shared papers, 2020 · strength 0.18
  18. Johanna C. Bendell · 2 shared papers, 2020 · strength 0.18
  19. Madappa N. Kundranda · 2 shared papers, 2020 · strength 0.18
  20. J. Marc Pipas · 2 shared papers, 2020 · strength 0.18
  21. Rocio García‐Carbonero · 1 shared paper, 2024 · strength 0.17
  22. José Luis Manzano Mozo · 2 shared papers, 2017–2020 · strength 0.13
  23. Rafael López‐López · 2 shared papers, 2015–2019 · strength 0.13
  24. Joaquina Martínez-Galán · 2 shared papers, 2017–2019 · strength 0.13
  25. Ruth Vera · 2 shared papers, 2017–2019 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.